• Vk
  • LinkedIn
  • Youtube
X7 Research
  • News
  • Registration strategy and Сonsulting
    • Budgeting
    • Registration strategy development
    • Study feasibility
    • Vendor selection
    • Data search and analysis
  • Clinical trials
    • Outsourcing CRAs in Russia and the EAEU
    • Development of medical documentation and biostatistics
    • Monitoring
    • Data-management
    • Patient home visits
    • Bioequivalence study
    • Therapeutic equivalence studies
    • Clinical trials of medical devices
  • Registration
    • Audit of the registration dossier
    • Bringing the registration dossier in compliance with the requirements of the EAEU
    • Conversion of registration dossier into XML format
    • PIL readability user testing
    • Translation of the Registration dossier
    • Turnkey registration
  • Post-authorization clinical studies
    • Phase IV studies
    • Non-interventional studies
    • Investigator-initiated studies
    • Post-authorisation safety study
    • Marketing research
  • Pharmacovigilance
    • QPPV in the EAEU
    • Safety monitoring of medical devices
    • Building a pharmacovigilance system
    • Safety in clinical trials
    • Pharmacovigilance audit
    • Pharmacovigilance contact person
  • Therapeutic expertise
    • Clinical trials in Oncology in the EAEU
  • Contact
  • EnglishEnglish
  • Menu

Did you know, that FDA unapproved drugs can be legally prescribed and used as treatment for patients in U.S?

04.03.2020/in News /by Evgeniy Makarevich

While it may come as a surprise to majority of people, it holds true. It’s imperative to note, that not every unapproved drug out there can be used in patient treatment, and FDA itself has clear guidelines of when it’s acceptable.

The exception is granted under one of the below conditions:

  • The drug is involved in an open drug efficacy study implementation program (DESI)- a program aimed at evaluating the efficacy of drugs that have been on the market prior to 1962
  • Healthcare professionals rely on the drug in treatment of serious medical conditions, where there are no drugs available for treatment of this conditions
  • There is an insufficient supply of a certain FDA approved drug
  • The use is authorized by the U.S. Secretary in diagnosis, monitoring, and treatment of serious conditions in an emergency situation

An individual patient can also request a drug, that is currently unapproved, through a licensed physician. Certain criteria must be met in order to accomplish that:

 

  • It must be determined that there is no alternative or comparable treatment currently on the market, and the risk of using the drug/device outweighs the risk from an untreated condition/disease
  • A sufficient evidence of safety and effectiveness of the drug through clinical trials
  • Use of the drug does not interfere with ongoing clinical investigations to support marketing approval
  • The sponsor, or the investigator, submits to the Secretary a description of use of the drug by a single individual, or a group of patients

When it comes to a more widespread use of unapproved drugs in a group of eligible patients, the sponsor, or physician, must prove to the Secretary, that the drug is intended for use in a life-threatening disease/condition, that there is no alternative therapy, that all the necessary clinical trials have been completed, and the sponsor is currently pursuing marketing authorization. Furthermore, a sufficient evidence of safety and efficacy of the drug must be provided.

While it may seem counterintuitive, the use of unapproved drugs is under constant control and very strict regulations from both, the FDA, and the U.S government itself. Each case of use of such drug is thoroughly studied, and the decisions are made on a case-by-case basis by the U.S. Secretary.

Such method of regulation ensures both, a tight enough control over unapproved medications, while still allowing for the special patient needs to be met, in case of an emerging necessity.

Share this entry
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail

YOU MAY ALSO BE INTERESTED IN

Publications
Readability User Testing of Package Information Leaflets (PIL) in EAEU
Read More
Publications
Remote clinical trial monitoring
Read More
Publications
Post-authorization studies of drug safety in Russia
Read More

RUBRICS

Registration strategy and Сonsulting

Clinical trials

Registration

Post-authorization clinical studies

Pharmacovigilance

LATEST PUBLICATIONS

  • Corrections to clinical trial documents due to COVID-19. Russian experience.
  • WHAT IS BIOEQUIVALENCE
  • THE VOLUME OF RUSSIAN PHARMACEUTICAL MARKET 2016-2019

Tags

bioequivalenceClinical trials in the CISfeasibilitymonitoringRadiopharmaceuticals

CONTACT

3 + 0 = ?

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.

PRIVACY

Use of this site constitutes your consent to our Privacy Policy.


SOCIAL RESPONSIBILITY

X7 Research’s primary responsibility is to help our clients in bringing medicines & products to the market efficiently and safely.

The Best CRO for Clinical Trials | Full-service Global CRO — X7 Research

The Best CRO in Pharma | Clinical Research Organisation — X7 Research

The Best Contract Research Organisation (CRO) | Trusted CRO — X7 Research

The Best Clinical Research Organisation (CRO): Full Service CRO | X7 Research

The Best CRO in Research | Trusted CRO for Your Trail — X7 Research

The Best Clinical Trial Company | Global Full-service CRO - X7 Research

The Best Pharma CROs: Clinical Trials for Drugs | X7 Research

The Best CROs Company: Clinical Trials with Global CRO — X7 Research

The Best Pre-clinical CRO: Safety Assessment With X7 Research

The Best Clinical Development | Trusted CRO for Your Product: X7 Research

The Best Biostatistical Consulting: Statistical Services | X7 Research

The Best Pharmacovigilance Consulting Services | CRO — X7 Research

Feasibility in Clinical Trials: What is a Feasibility in Clinical Trials?

Clinical Study Trials: What are Clinical Study Trials?

Category
Strategy and consulting
Clinical trials
Registration
Post-authorization clinical studies
Pharmacovigilance

Registration strategy and Сonsulting
Registration strategy development
Budgeting
Study feasibility
Vendor selection
Data search and analysis

Clinical trials
Development of medical documentation and biostatistics
Monitoring
Data management
Patient home visits
Bioequivalence study
Therapeutic equivalence studies

Registration
Audit of the registration dossier
Dossier eaeu
Conversion of registration dossier into xml format
Pil readability user testing
Turnkey registration

Post-authorization clinical studies
Phase iv studies
Non interventional studies
Investigator initiated studies
Post authorisation safety study
Marketing research

Pharmacovigilance
Building a pharmacovigilance system
Safety in clinical trials
Pharmacovigilance audit
Pharmacovigilance contact person

Blog
Contacts

© Copyright 2010-2023 - X7 Research. All rights reserved.
FDA approved a new breakthrough therapy for Cystic Fibrosis Clinical trials of vaccines in the EAEU
Scroll to top